Comparison of PAM50 intrinsic subtype profiles in matched primary and metastatic breast cancer samples from the CTC-MBC trial (NCT01322893) shows a significant shift towards more aggressive subtypes throughout tumor progression-MedSci.cn

Comparison of PAM50 intrinsic subtype profiles in matched primary and metastatic breast cancer samples from the CTC-MBC trial (NCT01322893) shows a significant shift towards more aggressive subtypes throughout tumor progression

Jorgensen, CLT; Forsare, C; Bendahl, PO; Larsson, AM; Lovgren, K; Aaltonen, K; Jansson, S; Ryden, L

CANCER RESEARCH, 2020; 80 (4):

科室
- - 订阅+
  - 更多科室
工具
服务